Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
EPIC: REDX
Market: AIM
Sector: Pharma & Biotech
Market Cap: 40.95M
Phone: +44 (0)151 706 4747
Address: Royal Liverpool Univeristy Hospital, Daulby Street, Liverpool L69 3GA.
Website: RedxPharma.com
Redx Pharma Plc

Redx Pharma Plc

Redx Pharma is focused on the discovery and development of proprietary, small molecule therapeutics to address areas of high unmet medical need, in cancer, immunology and infection. By improving the characteristics of existing drug classes, we aim to create differentiated, novel drugs.

Redx has an established portfolio of proprietary drug programs that it is developing alone and in partnership with leading pharmaceutical companies and healthcare bodies. Two of our high value programs are advancing into Phase I clinical development for gastric, biliary and pancreatic cancers, and leukaemia. It is our aim that our discoveries will provide a pipeline of potential assets to complement and combine with the drug portfolios of larger and emerging pharmaceutical companies.

Redx Pharma Plc

RedxPharma.com

Interactive graph

col 3
col 4
col 5
col 6

Redx Pharma Plc Timeline

CN Research

Redx Pharma - Entering the Clinical Stage

Redx Pharma, a drug discovery and development company focused on oncology, immunology and infectious diseases, is about to move its two lead candidates into the clinical stage.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use